A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and experienced less short-term impact on their daily lives when treated with MRI-guided, transurethral ultrasound ablation (TULSA) compared with robotic prostate surgery. The results of the CAPTAIN Trial were presented at the SIR 2026 Annual Scientific Meeting in Toronto…
Read More
